Another approach for targeting MYC signaling pathway in SCLC cells is represented by Aurora Kinase inhibitors (AKi), which showed elevated toxicity in SCLC cells carrying MYC amplification [3,18,19,20]. Here, MYC is linked to small cell lung carcinoma.